These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5396500)

  • 21. N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone.
    Zaremba M; Borowski J; Feliński J; Rozkiewicz D; Rozkiewicz M; Zaremba K; Czerwiński A; Borowski E
    J Chemother; 1989 Jul; 1(4 Suppl):243-5. PubMed ID: 16312386
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental study of a new fungistatic agent: R 10100 1-(1,2,3,4-tetrahydro-1-naphthyl)-5-(ethoxycarbonyl)-imidazole nitrate.
    Vanbreuseghem R; Van Cutsem J; Thienpont D
    Chemotherapy; 1967; 12(2):107-22. PubMed ID: 6053285
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experiences in the therapy of granulomatous candidiasis of children using clotrimazole (Bay b 5097)].
    Meinhof W
    Dermatol Monatsschr; 1973 Apr; 159(4):433-5. PubMed ID: 4726634
    [No Abstract]   [Full Text] [Related]  

  • 24. Sulconazole--a new antifungal for the skin.
    Drug Ther Bull; 1986 Aug; 24(17):67-8. PubMed ID: 3757794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antifungal action of Bay b 5097 in experimental coccidioidomycosis in mice].
    Vanbreuseghem R; De Vroey C; Takashio M; Swinne-Desgain D
    Mykosen; 1975 Jan; 18(1):25-8. PubMed ID: 1117888
    [No Abstract]   [Full Text] [Related]  

  • 26. [Investigations on the effectiveness of a new antimycotic through experimental keratomycosis in rabbits (author's transl)].
    Oggel K; de Decker W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975; 193(3):189-92. PubMed ID: 1078960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Variotin, a locally active antifungal antibiotic for the treatment of dermatomycoses. Experimental data and clinical evaluation].
    Krempl-Lamprecht L; Rieth H
    Mykosen; 1968 Mar; 11(3):239-42. PubMed ID: 4920914
    [No Abstract]   [Full Text] [Related]  

  • 28. The antifungal action of some imidazole derivatives.
    Trout GE; Levy PR
    S Afr J Med Sci; 1968 Oct; 33(3):91-3. PubMed ID: 5752911
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new antifungal agent for the treatment of systemic moniliasis following kidney transplantation].
    Wolf A; Pinggera WF; Stummvoll HK; Lobenwein-Weinegg E; Oppolzer R; Singer F
    Schweiz Med Wochenschr; 1973 Dec; 103(52):1883-6. PubMed ID: 4587171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Metastatic ophthalmia following candida septicemia. Experiences with the new oral antimycotic drug Bay b 5097].
    Freund J; Rüger K; Malchow H
    Klin Monbl Augenheilkd; 1972 Jul; 161(1):82-8. PubMed ID: 4539093
    [No Abstract]   [Full Text] [Related]  

  • 31. Ketoconazole--an antifungal drug for oral use.
    Drug Ther Bull; 1981 Nov; 19(23):91-2. PubMed ID: 6269823
    [No Abstract]   [Full Text] [Related]  

  • 32. [Imidazole preparations in mycology].
    Sheklakov ND; Rukavishnikova VM
    Vestn Dermatol Venerol; 1984 Jun; (6):51-8. PubMed ID: 6089467
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary report on the therapeutic results using BAY b 5097 in lung patients with a candida positive sputum].
    Riska N; Fröseth B; Mattson K; Nordman CH
    Pneumonologie; 1971; 145():406-16. PubMed ID: 4942799
    [No Abstract]   [Full Text] [Related]  

  • 35. [1 1/2 years' experience with ketoconazol - report of results].
    Fortschr Med; 1983 Jul; 101(25):1196-8. PubMed ID: 6309636
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of Candida septicaemia in severely burned patients with a new antimycotic, clotrimazole (Bay b 5097).
    Liljedahl SO; Frisk A; Wickman K
    Injury; 1972 Nov; 4(2):157-63. PubMed ID: 4578796
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful treatment of candida sepsis with the oral antimycotic Bay b 5097].
    Malchow H; Seybold D; Lange H; Freund J; Rüger K
    Dtsch Med Wochenschr; 1972 Jun; 97(24):935-8. PubMed ID: 4503519
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of a Candida infection with ketoconazole].
    Rempen A
    Med Welt; 1983 Mar; 34(10):308-9. PubMed ID: 6302435
    [No Abstract]   [Full Text] [Related]  

  • 39. The biological and toxicological properties of imazalil.
    Thienpont D; Van Cutsem J; Van Cauteren H; Marsboom R
    Arzneimittelforschung; 1981; 31(2):309-15. PubMed ID: 7194648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketoconazole in a case of chronic mucocutaneous candidiasis.
    Zachariae H; Laurberg G; Thestrup-Pedersen K
    Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.